RECRUITING

Innovations in Genicular Outcomes Registry

Talk to us

Conditions

Knee Osteoarthritis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[NSAIDs\]).

Official Title

Innovations in Genicular Outcomes Registry

Quick Facts

Study Start:2021-09-23
Study Completion:2025-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05495334

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening
  2. 2. Able to understand the informed consent and assessment questionnaires and have the ability to complete them in the opinion of the investigator
  3. 3. Have access to a smartphone or internet access with a computer/tablet to complete the questionnaires using the registry application
  1. 1. Actively enrolled in an investigational trial that would preclude patients from receiving the site's standard of care for knee OA pain or knee arthroplasty recovery protocol
  2. 2. Planning to have a surgery other than on the target knee

Contacts and Locations

Study Contact

Medical Information
CONTACT
1-855-793-9727
MedInfo@pacira.com

Study Locations (Sites)

Orthopedic Education and Research Institute of So Ca (Hoag)
Irvine, California, 92618
United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048
United States
MidState Orthopedics and Sports Medicine
Alexandria, Louisiana, 71301
United States
Louisiana State University /Ochsner
New Orleans, Louisiana, 70112
United States
Sinai Hospital of Baltimore
Baltimore, Maryland, 21215
United States
Henry M Jackson Foundation for the Advancement of Military Medicine/Walter Reed National Military Medical Center
Bethesda, Maryland, 20889
United States
OrthoNebraska Clinics
Omaha, Nebraska, 68144
United States
Jersey City Medical Center
Jersey City, New Jersey, 07302
United States
Genesee Orthopedics and Plastic Surgery (St. Elizabeth Med Center/ Apex Surgical Center)
New Hartford, New York, 13413
United States
Blue Nine Systems
Asheville, North Carolina, 28801
United States
Oklahoma Surgical Hospital
Tulsa, Oklahoma, 74137
United States
Penn Highlands DuBois
DuBois, Pennsylvania, 15824
United States
University Orthopedics Center
State College, Pennsylvania, 16801
United States
Campbell Clinic
Germantown, Tennessee, 38138
United States

Collaborators and Investigators

Sponsor: Pacira Pharmaceuticals, Inc

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-09-23
Study Completion Date2025-03-31

Study Record Updates

Study Start Date2021-09-23
Study Completion Date2025-03-31

Terms related to this study

Additional Relevant MeSH Terms

  • Knee Osteoarthritis